StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

CytoDyn's revenue for the twelve months ending May 31, 2022 was $266.00K. For fiscal 2023 it was $0, down 100.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2023May 31, 2023$0-100.0%
FY2022May 31, 2022$266.00K–
FY2021May 31, 2021$0–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2022CQ2 2022May 31, 2022$0–
Q3 FY2022CQ1 2022Feb 28, 2022$0–
Q2 FY2022CQ4 2021Nov 30, 2021$225.00K–
Q1 FY2022CQ3 2021Aug 31, 2021$41.00K–
Q4 FY2021CQ2 2021May 31, 2021$0–
Q3 FY2021CQ1 2021Feb 28, 2021$0–
Q2 FY2021CQ4 2020Nov 30, 2020$0–
Q1 FY2021CQ3 2020Aug 31, 2020$0–

More CytoDyn figures

See a number that looks wrong?